Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01492530 · ClinicalTrials.gov registry record · Phase 2
Men of African American Legacy Empowering Self
A Phase 2 study, sponsored by Charles Drew University of Medicine and Science.
- Completed
- Registry status
- Phase 2
- Development phase
- 437
- Enrollment target
NCT01492530: Completed Phase 2 study, sponsored by Charles Drew University of Medicine and Science.
NCT01492530 is a Phase 2 study that has completed, run by Charles Drew University of Medicine and Science. The registered enrollment target is 437 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (229% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01492530, a Phase 2 study, has completed, sponsored by Charles Drew University of Medicine and Science.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 437 participants
- Enrollment target
Study Summary
The MAALES Project is a community collaborative intervention designed to prevent HIV infection and transmission among African American men who have sex with both men and women. The investigators are a collaboration of researchers, community service providers and activists who are committed to developing and testing effective HIV prevention interventions that employ holistic and culturally relevant approaches. This includes recognizing the impact of forces such as racism, homophobia, heterosexism, sexism, and gender expectations on individual behavior and relationship dynamics in African American communities.
Primary Outcome
Determine the impact of the MAALES Intervention on (a) HIV- related sexual risk behaviors and (b) sex under the influence of drugs and alcohol among African American MSMW.
Interventions
- BEHAVIORAL Men of African American Legacy Empowering Self
- BEHAVIORAL Standard HIV Education & Risk Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 437 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-03 |
| Phase | Phase 2 |
What the finished NCT01492530 record still lists
NCT01492530 is an interventional study that assigns participants to a tested intervention. The registered 437 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (229% higher).
The record links to 0 conditions, and to 2 interventions - of which Men of African American Legacy Empowering Self is the first listed.
NCT01492530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01492530 about?
NCT01492530 is a clinical study titled "Men of African American Legacy Empowering Self". The MAALES Project is a community collaborative intervention designed to prevent HIV infection and transmission among African American men who have sex with both men and women. The investigators are a collaboration of researchers, community service providers and activists who are committed to develo...
What is the current status of trial NCT01492530?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 437 participants. The study started on 2007-08. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01492530?
The interventions under investigation include: Men of African American Legacy Empowering Self (BEHAVIORAL), Standard HIV Education & Risk Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01492530?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01492530's enrollment target sits among peer trials
437 89th of 2000 higher than 1,912 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia